George Christopher Eliades SEC EDGAR Filings (CIK 0001855251)

SEC EDGAR filings, ownership reports, and insider transactions for George Christopher Eliades.

Business address
C/O Oyster Point Pharma, Inc., 202 Carnegie Center, Suite 109, Princeton, NJ, 08540
Get insider transactions for this reporting owner
George Christopher Eliades has filed 5 SEC EDGAR filings since 05 Apr 2021

Latest Filings

Recent SEC filings for George Christopher Eliades including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 04 Jan 2023 03 Jan 2023 001-39112
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 08 Jun 2022 06 Jun 2022 001-39112
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Jun 2021 07 Jun 2021 001-39112
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 05 Apr 2021 02 Apr 2021 001-39112
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 05 Apr 2021 02 Apr 2021 001-39112

About this filer

George Christopher Eliades files with the SEC under CIK 0001855251. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages